US$ 24.99
fda warning on semaglutide warns about safety of 'off-brand' versions of Ozempic, Wegovy FDA Drug Recalls and Warnings:
Description
Aim The aim of this review is to critically evaluate the experimental evidence available for cinnamon in improving glycaemic targets in animal models and humans

Methods Adults with T2D treated with 2 glucose-lowering agents who initiated GLP-1 RAs or basal insulin from 2010 to 2019 were propensity-score matched (1:1) and followed until October 2021 (intention-to-treat [ITT])
After adjustment for baseline covariates, semaglutide was associated with greater weight reduction and LDL cholesterol improvement, whereas HbA1c reduction was comparable between groups

And when Boogie Pimps joins the party, things literally go round!...

Can you take GLP-1 with blood thinners

Rule 67/2007
